Bristol Myers Squibb (CELG-RI) Return on Sales (2009 - 2026)

Bristol Myers Squibb (CELG-RI) has 18 years of Return on Sales data on file, last reported at 0.0% in Q1 2026.

• Return on Sales for Q1 2026 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Sales advanced to 0.0% in Q1 2026 per CELG-RI's latest filing, from 0.0% in the prior quarter.
• Over five years, Return on Sales peaked at 0.0% in Q1 2026 and troughed at 0.01% in Q1 2024.
• A 5-year average of 0.0% and a median of 0.0% in 2022 frame the typical range for Return on Sales.
• The sharpest annual moves came in 2024 and 2025: Return on Sales decreased 1 bps in 2024, then rose 1 bps in 2025.
• A 5-year view of Return on Sales shows it stood at 0.0% in 2022, then retreated by 14 bps to 0.0% in 2023, then tumbled by 96 bps to 0.0% in 2024, then surged by 1311 bps to 0.0% in 2025, then soared by 168 bps to 0.0% in 2026.
• Business Quant data shows CELG-RI's Return on Sales at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.